22,298 Shares in The Allstate Co. (NYSE:ALL) Bought by Avanza Fonder AB

Avanza Fonder AB acquired a new stake in shares of The Allstate Co. (NYSE:ALLFree Report) in the fourth quarter, HoldingsChannel.com reports. The fund acquired 22,298 shares of the insurance provider’s stock, valued at approximately $4,299,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. State Street Corp boosted its holdings in shares of Allstate by 1.1% during the 3rd quarter. State Street Corp now owns 11,496,306 shares of the insurance provider’s stock valued at $2,190,758,000 after purchasing an additional 126,922 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Allstate by 1.2% in the third quarter. Geode Capital Management LLC now owns 6,228,581 shares of the insurance provider’s stock worth $1,178,164,000 after buying an additional 74,537 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its stake in Allstate by 18.7% during the third quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock valued at $569,114,000 after buying an additional 472,040 shares during the last quarter. Raymond James & Associates grew its holdings in Allstate by 10.6% during the 3rd quarter. Raymond James & Associates now owns 1,517,800 shares of the insurance provider’s stock valued at $287,851,000 after buying an additional 145,986 shares in the last quarter. Finally, Pathway Financial Advisers LLC increased its stake in Allstate by 18,472.5% in the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock worth $199,642,000 after acquiring an additional 1,047,019 shares during the last quarter. Institutional investors own 76.47% of the company’s stock.

Allstate Trading Down 1.2 %

NYSE ALL opened at $188.85 on Friday. The Allstate Co. has a 12 month low of $150.17 and a 12 month high of $209.88. The company’s 50-day moving average price is $195.89 and its 200-day moving average price is $186.12. The stock has a market cap of $50.01 billion, a PE ratio of 12.23, a PEG ratio of 1.35 and a beta of 0.52. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.43.

Allstate (NYSE:ALLGet Free Report) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping analysts’ consensus estimates of $2.20 by $1.71. The business had revenue of $16.63 billion for the quarter, compared to the consensus estimate of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The company’s revenue for the quarter was up 14.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.81 EPS. Equities research analysts forecast that The Allstate Co. will post 16.45 earnings per share for the current year.

Allstate Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th were given a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a yield of 1.95%. The ex-dividend date was Friday, November 29th. Allstate’s dividend payout ratio (DPR) is presently 23.83%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. UBS Group raised their target price on shares of Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a report on Monday, November 4th. The Goldman Sachs Group lifted their price objective on shares of Allstate from $209.00 to $230.00 and gave the stock a “buy” rating in a research note on Friday, November 15th. JPMorgan Chase & Co. upped their target price on shares of Allstate from $205.00 to $207.00 and gave the company an “overweight” rating in a research report on Thursday, October 10th. BMO Capital Markets lifted their price target on Allstate from $205.00 to $214.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. Finally, Jefferies Financial Group upped their price objective on Allstate from $231.00 to $267.00 and gave the company a “buy” rating in a research report on Friday, November 8th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $218.13.

Get Our Latest Stock Analysis on ALL

Allstate Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Further Reading

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALLFree Report).

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.